BANK OF MONTREAL /CAN/ - RIGEL PHARMACEUTICALS INC ownership

RIGEL PHARMACEUTICALS INC's ticker is RIGL and the CUSIP is 766559603. A total of 151 filers reported holding RIGEL PHARMACEUTICALS INC in Q4 2020. The put-call ratio across all filers is 0.88 and the average weighting 0.1%.

Quarter-by-quarter ownership
BANK OF MONTREAL /CAN/ ownership history of RIGEL PHARMACEUTICALS INC
ValueSharesWeighting
Q2 2023$16,218
-2.6%
10,073
-8.7%
0.00%
Q4 2022$16,659
-2.0%
11,032
+5.7%
0.00%
Q3 2022$17,000
+41.7%
10,434
+1.6%
0.00%
Q2 2022$12,000
-65.7%
10,267
-6.6%
0.00%
Q1 2022$35,000
-14.6%
10,990
-27.8%
0.00%
Q4 2021$41,000
-96.8%
15,221
-95.2%
0.00%
-100.0%
Q3 2021$1,283,000
-14.9%
319,890
-3.7%
0.00%0.0%
Q2 2021$1,508,000
+84.4%
332,183
+35.0%
0.00%0.0%
Q1 2021$818,000
-28.2%
246,099
-26.0%
0.00%0.0%
Q4 2020$1,139,000
+88.9%
332,751
+39.2%
0.00%0.0%
Q3 2020$603,000
-20.0%
239,063
-42.3%
0.00%0.0%
Q2 2020$754,000
+61.5%
413,981
+26.8%
0.00%0.0%
Q1 2020$467,000
-33.1%
326,608
+0.2%
0.00%0.0%
Q4 2019$698,000
+1838.9%
326,063
+1633.5%
0.00%
Q3 2019$36,000
-18.2%
18,809
+10.6%
0.00%
Q2 2019$44,000
+450.0%
17,000
+443.0%
0.00%
Q1 2019$8,000
-20.0%
3,131
-20.7%
0.00%
Q4 2018$10,000
-94.0%
3,949
-92.4%
0.00%
Q3 2018$168,000
+20.9%
52,243
+6.1%
0.00%
Q2 2018$139,000
+6850.0%
49,230
+5437.7%
0.00%
Q3 2017$2,000889
+3765.2%
0.00%
Q2 2017$0
-100.0%
23
-98.5%
0.00%
Q3 2016$6,000
-25.0%
1,500
-30.6%
0.00%
Q2 2014$8,000
+60.0%
2,160
+56.1%
0.00%
Q3 2013$5,0001,3840.00%
Other shareholders
RIGEL PHARMACEUTICALS INC shareholders Q4 2020
NameSharesValueWeighting ↓
DAFNA Capital Management LLC 1,847,087$4,119,0003.26%
Sio Capital Management, LLC 1,333,696$2,974,0001.52%
Boxer Capital, LLC 700,000$1,561,0001.38%
Palo Alto Investors LP 5,386,534$12,012,0000.91%
ACUTA CAPITAL PARTNERS, LLC 747,748$1,667,0000.80%
SENZAR ASSET MANAGEMENT, LLC 1,443,003$3,217,897,0000.70%
Ghost Tree Capital, LLC 800,000$1,784,0000.52%
NEA Management Company, LLC 3,243,150$7,232,0000.38%
Rhenman & Partners Asset Management AB 850,000$1,896,0000.34%
Rock Springs Capital Management LP 1,750,000$3,903,0000.29%
View complete list of RIGEL PHARMACEUTICALS INC shareholders